1	Multifactor	Multifactor	_	_	_	_	_	_	_
2	cis-dominant	cis-dominant	_	_	_	_	_	_	_
3	negative	negative	_	_	_	_	_	_	_
4	regulation	regulation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	anergized	anergize	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	molecular	molecular	_	_	_	_	_	_	_
3	mechanism	mechanism	_	_	_	_	_	_	_
4	underlying	underlie	_	_	_	_	_	_	_
5	IL-2	il-2	_	_	_	_	_	_	_
6	transcriptional	transcriptional	_	_	_	_	_	_	_
7	blockade	blockade	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	anergic	anergic	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	clones	clone	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	fully	fully	_	_	_	_	_	_	_
16	understood	understand	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	examine	examine	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	active	active	_	_	_	_	_	_	_
6	negative	negative	_	_	_	_	_	_	_
7	regulatory	regulatory	_	_	_	_	_	_	_
8	process	process	_	_	_	_	_	_	_
9	occurs	occur	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	we	we	_	_	_	_	_	_	_
12	created	create	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	reporter	reporter	_	_	_	_	_	_	_
15	construct	construct	_	_	_	_	_	_	_
16	containing	contain	_	_	_	_	_	_	_
17	as	as	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	enhancer	enhancer	_	_	_	_	_	_	_
20	four	four	_	_	_	_	_	_	_
21	copies	copy	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	NF-AT	NF-AT	_	_	_	_	_	_	_
25	site	site	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	one	one	_	_	_	_	_	_	_
28	copy	copy	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	octamer	octamer	_	_	_	_	_	_	_
32	site	site	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	4X	4x	_	_	_	_	_	_	_
35	NF-AT-Oct	NF-AT-Oct	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	construct	construct	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	only	only	_	_	_	_	_	_	_
5	slightly	slightly	_	_	_	_	_	_	_
6	reduced	reduce	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	1.3-fold	1.3-fold	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	its	its	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	when	when	_	_	_	_	_	_	_
14	stimulated	stimulate	_	_	_	_	_	_	_
15	under	under	_	_	_	_	_	_	_
16	anergic	anergic	_	_	_	_	_	_	_
17	conditions	condition	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	while	while	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	whole	whole	_	_	_	_	_	_	_
22	mouse	mouse	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	enhancer	enhancer	_	_	_	_	_	_	_
25	construct	construct	_	_	_	_	_	_	_
26	showed	show	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	reduction	reduction	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	4.3-fold	4.3-fold	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Addition	addition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	-176	-176	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	-96	-96	_	_	_	_	_	_	_
7	sequence	sequence	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	4X	4x	_	_	_	_	_	_	_
11	NF-AT-Oct	nf-at-oct	_	_	_	_	_	_	_
12	construct	construct	_	_	_	_	_	_	_
13	did	do	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	impart	impart	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	ability	ability	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	be	be	_	_	_	_	_	_	_
20	affected	affect	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	anergy	anergy	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	but	but	_	_	_	_	_	_	_
25	addition	addition	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	-236	-236	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	-96	-96	_	_	_	_	_	_	_
31	sequence	sequence	_	_	_	_	_	_	_
32	did	do	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	demonstrating	demonstrate	_	_	_	_	_	_	_
35	that	that	_	_	_	_	_	_	_
36	anergy	anergy	_	_	_	_	_	_	_
37	is	be	_	_	_	_	_	_	_
38	an	an	_	_	_	_	_	_	_
39	active	active	_	_	_	_	_	_	_
40	inhibitory	inhibitory	_	_	_	_	_	_	_
41	process	process	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	that	that	_	_	_	_	_	_	_
44	more	more	_	_	_	_	_	_	_
45	than	than	_	_	_	_	_	_	_
46	the	the	_	_	_	_	_	_	_
47	presence	presence	_	_	_	_	_	_	_
48	of	of	_	_	_	_	_	_	_
49	the	the	_	_	_	_	_	_	_
50	-150	-150	_	_	_	_	_	_	_
51	AP-1	ap-1	_	_	_	_	_	_	_
52	binding	binding	_	_	_	_	_	_	_
53	site	site	_	_	_	_	_	_	_
54	(	(	_	_	_	_	_	_	_
55	-152	-152	_	_	_	_	_	_	_
56	to	to	_	_	_	_	_	_	_
57	-147	-147	_	_	_	_	_	_	_
58	)	)	_	_	_	_	_	_	_
59	is	be	_	_	_	_	_	_	_
60	required	require	_	_	_	_	_	_	_
61	to	to	_	_	_	_	_	_	_
62	mediate	mediate	_	_	_	_	_	_	_
63	the	the	_	_	_	_	_	_	_
64	effect	effect	_	_	_	_	_	_	_
65	.	.	_	_	_	_	_	_	_

1	Mutational	mutational	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	-236	-236	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	-96	-96	_	_	_	_	_	_	_
8	sequence	sequence	_	_	_	_	_	_	_
9	indicated	indicate	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	presence	presence	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	-130	-130	_	_	_	_	_	_	_
17	AP-1-like	ap-1-like	_	_	_	_	_	_	_
18	site	site	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	-187	-187	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	-181	-181	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	-150	-150	_	_	_	_	_	_	_
27	proximal	proximal	_	_	_	_	_	_	_
28	AP-1	ap-1	_	_	_	_	_	_	_
29	site	site	_	_	_	_	_	_	_
30	were	be	_	_	_	_	_	_	_
31	necessary	necessary	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	observe	observe	_	_	_	_	_	_	_
34	anergy	anergy	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	-180	-180	_	_	_	_	_	_	_
4	site	site	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	not	not	_	_	_	_	_	_	_
7	required	require	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	trans-activation	trans-activation	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	it	it	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	possible	possible	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	confirm	confirm	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	mutation	mutation	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	normal	normal	_	_	_	_	_	_	_
21	mouse	mouse	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	enhancer	enhancer	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	this	this	_	_	_	_	_	_	_
26	site	site	_	_	_	_	_	_	_
27	is	be	_	_	_	_	_	_	_
28	absolutely	absolutely	_	_	_	_	_	_	_
29	essential	essential	_	_	_	_	_	_	_
30	for	for	_	_	_	_	_	_	_
31	anergy	anergy	_	_	_	_	_	_	_
32	induction	induction	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	simplest	simple	_	_	_	_	_	_	_
3	model	model	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	explain	explain	_	_	_	_	_	_	_
6	these	these	_	_	_	_	_	_	_
7	results	result	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	anergy	anergy	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	mediated	mediate	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	complex	complex	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	multiple	multiple	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	factors	factor	_	_	_	_	_	_	_
20	that	that	_	_	_	_	_	_	_
21	exert	exert	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	cis-acting	cis-acting	_	_	_	_	_	_	_
24	dominant	dominant	_	_	_	_	_	_	_
25	negative	negative	_	_	_	_	_	_	_
26	regulatory	regulatory	_	_	_	_	_	_	_
27	effect	effect	_	_	_	_	_	_	_
28	on	on	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	trans-activation	trans-activation	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	IL-2	il-2	_	_	_	_	_	_	_
34	gene	gene	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

